Several studies indicate that cholesterol esterification is deregulated in cancers. The present study aimed to characterize the role of cholesterol esterification in proliferation and invasion of two tumor cells expressing an activated CCK2R. A significant increase in cholesterol esterification and activity of Acyl-coenzyme A:cholesterol acyltransferase (ACAT) was measured in tumor cells expressing a constitutively activated oncogenic mutant of the CCK2R (CCK2R-E151A cells) compared with non-tumor cells expressing the wild type CCK2R (CCK2R-WT cells).
Introduction
The cholecystokinin 2 receptor (CCK2R) is a G protein-coupled receptor that mediates important physiological functions by binding cholecystokinin and gastrin peptides (1, 2) . The CCK2R regulates the growth of normal and neoplastic gastrointestinal mucosal cells and the growth of different cells outside the digestive system (3) (4) (5) (6) (7) (8) (9) (10) (11) . The growth promoting action of the CCK2R has led to extensive investigations of its role in carcinogenesis and its expression in cancer. The expression of the CCK2R has been reported on malignant adenocarcinomas arising within all areas of the gastrointestinal tract mucosa, hepatomas and colorectal liver metastases, as well as in different cancers of neuroendocrine origin (8, (12) (13) (14) (15) . CCK2R expression may also be coupled with the co-expression of gastrin and CCK in different human tumors and cancer cell lines. A permanent activation of the CCK2R by a gastrin/CCK-CCK2R autocrine loop has been reported to promote cell growth in different tumor cells (4, (14) (15) (16) (17) (18) (19) (20) .
responsive genes and activation of ornithine decarboxylase (ODC) (6) . More recently, gastrin has been shown to activate cell proliferation in colorectal tumors by a mechanism involving the phosphorylation and degradation of the nuclear receptor PPARγ, a transcriptional factor reported to lower cholesterol metabolism when activated by agonist ligands (22) . A link between CCK2R activation and the regulation of cholesterol metabolism has recently been reported in neuronal cells. Indeed, PC12 cells transfected with the CCK2R regulated a set of genes involved in cholesterol metabolism in response to CCK (23) . However to date no studies have implicated the cholesterol metabolism in the growth promoting effects of the CCK2R in tumor cells.
Cholesterol is a crucial component of cell membranes that plays an important role in the organization of lipid bilayers and is essential for membrane biogenesis and cell proliferation. In addition cholesterol has been shown to modulate the functions of G protein coupled-receptors, and to participate in several membrane trafficking and transmembrane signaling processes (24-QIAmp RNA kit (Quiagen). RNA integrity was measured using an Agilent 2100 Bioanalyzer.
The DNA strand synthesis was carried out using 1 µg of DNase-treated RNA with the iScript TM cDNA Synthesis kit (BIO-RAD) following the protocol provided by the manufacturer. Real time PCR was carried out using the icycler iQ TM Real Time Detection system (BIO-RAD).
Amplification reactions were done with the iQ TM SYBR Green Supermix (BIO-RAD 
Results
To study the pattern of cholesterol esterification in cell expressing the CCK2R, we first used NIH-3T3 clones previously generated that express similar levels of wild-type (CCK2R-WT cells, clones WT4 and WT5) and mutated receptors (CCK2R-E151A cells, clones M1 and M40), as well as two clones expressing the empty vector (control cells, clones C20 and C50) (21) . In the previous study, the constitutive activity of the CCK2R-E151A mutant expressed in NIH-3T3 cells was associated with enhanced cell proliferation and invasion as well as the formation of tumors in nude mice while no such effects were observed with cells expressing the CCK2R wild type. To identify the intracellular signaling pathways coupling the constitutive CCK2R-E151A mutant to the formation of cholesteryl esters, we next examined the effects of different inhibitors of the main signaling pathways known to be activated by the CCK2R and/or the CCK2R-E151A
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mutant. As a control we used the ACAT inhibitor Sah 58-035 (25 µM) that completely inhibited the formation of cholesteryl esters (Fig. 3A) . As we showed that the CCK2R-E151A mutant constitutively activated ornithine decarboxylase (ODC) (21), we first studied the effect of polyamine depletion on cholesteryl ester formation by treating the CCK2R-E151A cells with α- indicating that ODC activity is not involved in cholesteryl ester formation.
Since we had also shown that the CCK2R-E151A mutant was linked to an increase in phosphatidylinositol hydrolysis (21) which is necessary to activate DAG-sensitive classical and novel PKC, we tested inhibitors of these PKC. As shown in Fig. 3A , the involvement of cPKC and nPKC was studied by using calphostin C, an inhibitor of diacylglycerol-dependent PKC isoforms and the calcium chelator BAPTA, an inhibitor of cPKC. These two inhibitors were ineffective in inhibiting cholesteryl ester formation, instead the inhibition of these PKCs increased cholesteryl ester formation. By contrast, Gö6983, an inhibitor of cPKCs, nPKCs and the atypical PKC (aPKc) PKCζ (38), completely abolished the basal formation of cholesteryl esters ( Fig. 3A) . Since the involvement of cPKC and nPKC isoforms in the increase in cholesteryl ester formation was ruled out by experiments using calphostin C and BAPTA, these data would suggest an involvement of PKCζ. This was confirmed by using a dominant negative mutant of PKCζ that completely inhibited the constitutive formation of cholesteryl esters when expressed in the CCK2R-E151A cells (Fig. 3B ).
We then investigated the contribution of the mitogen-activated protein kinases MEK/ERK1/2, a pathway activated by the CCK2R that has been reported to be dependent on both DAG-sensitive and DAG-insensitive PKC. As shown in Fig. 3A , the formation of 6B ). In a similar manner, ACAT activity was completely inhibited with Sah 58-035 and by 84 % and 73 % with L365 260 and YM22 respectively (Fig. 6C) .
We then characterized whether PKCζ and ERK1/2 were also involved in cholesteryl ester formation in U87 cells. As shown in Fig. 6A , cholesteryl ester production was not inhibited by BAPTA (lane 5) or calphostin C (lane 6) but instead both inhibitors increased their formation. In contrast, cholesterol esterification was inhibited by 93 % and 85 % with Gö6983 (lane 7) and PD98059 (lane 8) respectively, indicating that cholesteryl ester formation is mainly dependent on PKC ζ and MEK/ERK1/2. We then determined whether cholesteryl esters formed by the activated CCK2R were involved in U87 proliferation and invasion. The growth rate of U87 cells was shown inhibited in a time-dependent manner by Sah 58-035, L365260 and YM022 (Fig. 6D) .
After 72 h treatment, U87 proliferation was inhibited by 32 % with Sah 58-035 and by 38 % and 56 % with L365260 and YM022 respectively, (Fig. 6D ). In addition, the invasiveness of the U87 cells was inhibited by 60 % with Sah 58-035, 80 % with L365206 and 61 % with YM22 ( Fig.   6E ). Together these results indicate that cholesteryl ester formation produced by the CCK2R contributes to the proliferation and invasiveness of these cells. (46, 47). We showed that Tamoxifen and selective AEBS ligands induced tumor cell differentiation and apoptosis through the production of oxysterols and that this mechanism could account for their anti-tumor and chemo-preventative actions. Interestingly, we previously reported that Tamoxifen is an inhibitor of ACAT (35). This effect could also favor the production of oxysterols that are necessary for its anti-tumor effects (46, 47). Base on these different studies, it could be hypothesized that increase cholesterol esterification could be a mechanism used by tumor cells to quench or prevent the cytotoxic effects of oxysterols. These different studies and the present study suggest that ACAT is an important target for anti-cancer therapy or prevention.
Discussion
In conclusion, the originality of our study is to link the activation of a G protein-coupled receptor to cell proliferation and invasion via the stimulation of the ACAT/cholesterol esterification pathway. The ACAT/cholesterol esterification pathway thus appears as a new signaling pathway for the CCK2R that should be targeted for anti-cancer drug screening and discovery. 
